About REV THERAPEUTICS INC
Rev Therapeutics is a company developing a novel small molecule inhibitor to treat cardiac surgery-associated acute kidney injury.
Development of novel small molecule inhibitorsResearch and development in medical treatments
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to REV THERAPEUTICS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.